Stay updated on Olaptesed with Pembrolizumab in Colorectal and Pancreatic Clinical Trial
Sign up to get notified when there's something new on the Olaptesed with Pembrolizumab in Colorectal and Pancreatic Clinical Trial page.

Latest updates to the Olaptesed with Pembrolizumab in Colorectal and Pancreatic Clinical Trial page
- Check5 days agoNo Change Detected
- Check12 days agoChange DetectedFooter updates include adding Revision: v3.3.3 and removing HHS Vulnerability Disclosure and Revision: v3.3.2.SummaryDifference0.1%

- Check19 days agoNo Change Detected
- Check26 days agoNo Change Detected
- Check41 days agoChange DetectedThe page revision updated from v3.2.0 to v3.3.2, reflecting a minor label change with no impact on study data or page functionality. To avoid being alerted by small changes, set an alert condition by clicking below.SummaryDifference0.1%

- Check48 days agoChange Detected- Removal of the bottom-of-page banner about lapse in government funding and potential delays. This does not affect the study details or outcomes presented on the page.SummaryDifference0.4%

- Check62 days agoChange DetectedNo significant changes detected on the page; core study details, eligibility criteria, and interventions remain the same.SummaryDifference0.4%

- Check91 days agoChange DetectedAdded a government-operating-status notice and new version v3.2.0; removed old version v3.1.0.SummaryDifference3%

- Check98 days agoChange DetectedUpdated the page from revision v3.0.2 to v3.1.0, indicating a version upgrade with no other content changes.SummaryDifference0.1%

Stay in the know with updates to Olaptesed with Pembrolizumab in Colorectal and Pancreatic Clinical Trial
Enter your email address, and we'll notify you when there's something new on the Olaptesed with Pembrolizumab in Colorectal and Pancreatic Clinical Trial page.